Molazadeh N, Filippatou AG, Vasileiou ES, Levy M, et al. Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder. J Neuroimmunol 2021;360:577702.
PMID: 34547512